Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Encompass Health (EHC)

Encompass Health appoints Cain A. Hayes to board of directors

Neutral Impact 2 of 5 leadership Written later

Encompass Health's board elected Cain A. Hayes as a director on January 30, 2026, and the company announced the appointment on February 2, 2026. The board has determined Hayes is independent under NYSE listing standards, and he has not yet been named to a committee. The filing reports no financial results or guidance, so the change is a board-composition update rather than a direct financial event.

Key points

  • Board elected Cain A. Hayes as director on January 30, 2026, on the recommendation of the Nominating/Corporate Governance Committee
  • Board has determined Hayes is independent under NYSE listing standards; no committee assignment yet
  • Hayes retired as president and CEO of Point32Health, Inc. in 2024 and previously led Gateway Health Plan, Inc.
  • Compensation follows the standard nonemployee director practices described in the April 1, 2025 proxy statement

The filing

CompanyEncompass Health (EHC)
Form8-K, current report
Filed with the SECFeb 2, 2026, 4:39 PM ET
Accession number0000785161-26-000025

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:12 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 02, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.